04:05 AM EDT, 04/11/2024 (MT Newswires) -- NeuroSense Therapeutics ( NRSN ) said late Wednesday it has agreed to sell approximately 3 million ordinary shares in a registered direct offering to a healthcare-focused institutional investor and warrants to purchase up to about 3 million shares in a concurrent private placement at a combined price of $1.50 per share for total expected gross proceeds of $4.5 million.

The warrants will be immediately exercisable at a rate of $1.50 per share and will be valid for five years from initial exercise date.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close on or about April 15, subject to customary closing conditions.

Price: 1.6, Change: -0.06, Percent Change: -3.61